All Stories

  1. Development of a Polyclonal Antibody for the Immunoanalysis of Ochratoxin A (OTA) by Employing a Specially Designed Synthetic OTA Derivative as the Immunizing Hapten

    Article • Toxins, August 2025, MDPI AG

    Dr. Evangelia Livaniou

  2. Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives

    Article • International Journal of Molecular Sciences, June 2024, MDPI AG

    Dr. Evangelia Livaniou

  3. Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives

    Article • Biology, December 2023, MDPI AG

    Dr. Evangelia Livaniou

  4. Immunosensors for Autoimmune-Disease-Related Biomarkers: A Literature Review

    Article • Sensors, July 2023, MDPI AG

    Dr. Evangelia Livaniou

  5. Life-threatening arrhythmogenic CaM mutations disrupt CaM binding to a distinct RyR2 CaM-binding pocket

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, April 2023, Elsevier

    Dr. Evangelia Livaniou

  6. Cortisol Immunosensors: A Literature Review

    Article • Biosensors, February 2023, MDPI AG

    Dr. Evangelia Livaniou

  7. Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo Investigation

    Article • Current Medicinal Chemistry, December 2022, Bentham Science Publishers

    Dr. Evangelia Livaniou, Eleftheria Klagkou

  8. Fast and Accurate Determination of Minute Ochratoxin A Levels in Cereal Flours and Wine with the Label-Free White Light Reflectance Spectroscopy Biosensing Platform

    Article • Biosensors, October 2022, MDPI AG

    Dr. Evangelia Livaniou

  9. Recent Developments in the Field of Optical Immunosensors Focusing on a Label-Free, White Light Reflectance Spectroscopy-Based Immunosensing Platform

    Article • Sensors, July 2022, MDPI AG

    Dr. Evangelia Livaniou

  10. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker

    Article • Cells, April 2022, MDPI AG

    Dr. Evangelia Livaniou

  11. Fast and Accurate Determination of Minute Ochratoxin A Levels in Cereal Flours: Towards Application at the Field

    Article • February 2022, MDPI AG

    Dr. Evangelia Livaniou

  12. Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives

    Article • Vaccines, November 2021, MDPI AG

    Dr. Evangelia Livaniou

  13. IgY technology: Methods for developing and evaluating avian immunoglobulins for the in vitro detection of biomolecules

    Article • World Journal of Methodology, September 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Evangelia Livaniou

  14. Fast and Sensitive Determination of the Fungicide Carbendazim in Fruit Juices with an Immunosensor Based on White Light Reflectance Spectroscopy

    Article • Biosensors, May 2021, MDPI AG

    Dr. Evangelia Livaniou

  15. Fluorescence Enhancement on Silver-Plated Plasma Micro-Nanostructured 3D Polymeric Microarray Substrates for Multiplex Mycotoxin Detection

    Article • Processes, February 2021, MDPI AG

    Dr. Evangelia Livaniou

  16. Rapid detection of mozzarella and feta cheese adulteration with cow milk through a silicon photonic immunosensor

    Article • The Analyst, January 2021, Royal Society of Chemistry

    Dr. Evangelia Livaniou

  17. A White Light Reflectance Spectroscopy Label-Free Biosensor for the Determination of Fungicide Carbendazim

    Article • November 2020, MDPI AG

    Dr. Evangelia Livaniou

  18. In Vitro Immunodetection of Prothymosin Alpha in Normal and Pathological Conditions

    Article • Current Medicinal Chemistry, September 2020, Bentham Science Publishers

    Dr. Evangelia Livaniou, Wolfgang Voelter

  19. Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide

    Article • Cancers, November 2019, MDPI AG

    Dr. Evangelia Livaniou

  20. Development of a specific IgY-based ELISA for prothymosin alpha, a bioactive polypeptide with diagnostic and therapeutic potential

    Article • Heliyon, October 2019, Elsevier

    Dr. Evangelia Livaniou

  21. Development of Antibodies and Immunoassays for Carbamate Pesticides

    Article • Current Organic Chemistry, January 2018, Bentham Science Publishers

    Dr. Evangelia Livaniou

  22. White light reflectance spectroscopy biosensing system for fast quantitative prostate specific antigen determination in forensic samples

    Article • Talanta, December 2017, Elsevier

    Dr. Evangelia Livaniou

  23. Prothymosin Alpha: An Alarmin and More...

    Article • Current Medicinal Chemistry, July 2017, Bentham Science Publishers

    Dr. Evangelia Livaniou

  24. In vivo biodistribution and imaging studies with a 99m Tc-radiolabeled derivative of the C-terminus of prothymosin alpha in mice bearing experimentally-induced inflammation

    Article • European Journal of Pharmaceutics and Biopharmaceutics, April 2017, Elsevier

    Dr. Evangelia Livaniou

  25. Antigen unmasking enhances visualization efficacy of the oocyte activation factor, phospholipase C zeta, in mammalian sperm

    Article • Molecular Human Reproduction, December 2016, Oxford University Press (OUP)

    Dr. Evangelia Livaniou

  26. Distinctive malfunctions of calmodulin mutations associated with heart RyR2-mediated arrhythmic disease

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, November 2015, Elsevier

    Dr. Evangelia Livaniou

  27. Specific in vitro binding of a new 99mTc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils

    Article • International Journal of Pharmaceutics, May 2015, Elsevier

    Dr. Evangelia Livaniou

  28. New labeled derivatives of the neuroprotective peptide colivelin: Synthesis, characterization, and first in vitro and in vivo applications

    Article • Archives of Biochemistry and Biophysics, February 2015, Elsevier

    Dr. Evangelia Livaniou

  29. Commercially available chemicals as immunizing haptens for the development of a polyclonal antibody recognizing carbendazim and other benzimidazole-type fungicides

    Article • Chemosphere, January 2015, Elsevier

    Dr. Evangelia Livaniou

  30. Altered RyR2 regulation by the calmodulin F90L mutation associated with idiopathic ventricular fibrillation and early sudden cardiac death

    Article • FEBS Letters, July 2014, Wiley

    Dr. Evangelia Livaniou

  31. Visualization of the membrane engineering concept: evidence for the specific orientation of electroinserted antibodies and selective binding of target analytes

    Article • Journal of Molecular Recognition, November 2013, Wiley

    Dr. Evangelia Livaniou

  32. Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the 99mTc core

    Article • Bioorganic & Medicinal Chemistry, November 2013, Elsevier

    Dr. Evangelia Livaniou

  33. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100–109) in sera of mice infected with bacteria

    Article • Journal of Immunological Methods, September 2013, Elsevier

    Dr Vasilis J Promponas, Dr. Evangelia Livaniou

  34. Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility

    Article • Fertility and Sterility, January 2013, Elsevier

    Dr. Evangelia Livaniou

  35. Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6

    Article • Chemistry Central Journal, December 2012, Springer Science + Business Media

    Dr. Evangelia Livaniou

  36. Complexes of an Alpha Thymosin Derivative with185/187Re and99mTc: Structural Analysis and Initial Biological Evaluation

    Article • Chemical Biology & Drug Design, July 2012, Wiley

    Dr. Evangelia Livaniou

  37. Structural modifications of 99mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting

    Article • International Journal of Pharmaceutics, July 2012, Elsevier

    Dr. Evangelia Livaniou

  38. Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy

    Article • Medical Oncology, February 2012, Springer Science + Business Media

    Dr. Evangelia Livaniou

  39. Divergent effect of mammalian PLCζ in generating Ca2+ oscillations in somatic cells compared with eggs

    Article • Biochemical Journal, August 2011, Portland Press Ltd.

    Dr. Evangelia Livaniou

  40. Solid-Phase Synthesis of a Biotin Derivative and its Application to the Development of Anti-Biotin Antibodies

    Article • Applied Biochemistry and Biotechnology, December 2009, Springer Science + Business Media

    Dr. Evangelia Livaniou

  41. In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives

    Article • Peptides, December 2009, Elsevier

    Dr. Evangelia Livaniou

  42. Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging

    Article • European Journal of Medicinal Chemistry, October 2009, Elsevier

    Dr. Evangelia Livaniou

  43. Spacer Site Modifications for the Improvement of the in Vitro and in Vivo Binding Properties of 99mTc-N3S-X-Bombesin[2−14] Derivatives

    Article • Bioconjugate Chemistry, April 2009, American Chemical Society (ACS)

    Dr. Evangelia Livaniou

  44. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues

    Article • Peptides, November 2008, Elsevier

    Dr. Evangelia Livaniou

  45. Immunocytological and Preliminary Immunohistochemical Studies of Prothymosin α, a Human Cancer–associated Polypeptide, With a Well-characterized Polyclonal Antibody

    Article • Journal of Histochemistry & Cytochemistry, July 2008, SAGE Publications

    Dr. Evangelia Livaniou

  46. Determination of natural olive fruit fly pheromone in insect samples by enzyme linked immunoassays

    Article • Talanta, January 2008, Elsevier

    Dr. Evangelia Livaniou

  47. Immunological Potential ofHelix vulgarisandRapana venosaHemocyanins

    Article • Immunological Investigations, January 2008, Taylor & Francis

    Dr. Evangelia Livaniou

  48. Solid-phase Synthesis of a Peptide Derivative of Thymosin alpha1 and Initial Studies on its99mTc-Radiolabelling

    Article • Chemical Biology & Drug Design, July 2007, Wiley

    Dr. Evangelia Livaniou

  49. Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer’s disease

    Article • Biochemical and Biophysical Research Communications, October 2006, Elsevier

    Dr. Evangelia Livaniou

  50. Synthesis, Characterization, and Biological Evaluation of M(I)(CO)3(NNO) Complexes (M = Re, 99mTc) Conjugated to 2-(4-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals

    Article • Journal of Medicinal Chemistry, August 2006, American Chemical Society (ACS)

    Dr. Evangelia Livaniou

  51. The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients

    Article • Medical Oncology, February 2006, Springer Science + Business Media

    Professor Monica Neagu, Dr. Evangelia Livaniou

  52. Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha

    Article • Peptides, January 2006, Elsevier

    Dr. Evangelia Livaniou

  53. Solution structure of humanin, a peptide against Alzheimer’s disease-related neurotoxicity

    Article • Biochemical and Biophysical Research Communications, April 2005, Elsevier

    Dr. Evangelia Livaniou

  54. High-yield, solid-phase synthesis of humanin, an Alzheimer's disease associated, novel 24-mer peptide which contains a difficult sequence

    Article • Journal of Peptide Science, October 2004, Wiley

    Dr. Evangelia Livaniou

  55. Synthesis of Haptens and Development of an Immunoassay for the Olive Fruit Fly Pheromone

    Article • Journal of Agricultural and Food Chemistry, June 2004, American Chemical Society (ACS)

    Dr. Evangelia Livaniou

  56. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles

    Article • International Journal of Pharmaceutics, June 2003, Elsevier

    Dr. Evangelia Livaniou

  57. Lymphocytes from bipolar and schizophrenic patients share common biochemical markers related to histone synthesis and histone cell membrane localization characteristic of an activated state

    Article • Psychiatry Research, May 2003, Elsevier

    Dr. Evangelia Livaniou

  58. Comparative evaluation of four trityl-type amidomethyl polystyrene resins in Fmoc solid phase peptide synthesis

    Article • Journal of Peptide Science, January 2003, Wiley

    Dr. Evangelia Livaniou

  59. Synthesis and angiogenetic activity in the chick chorioallantoic membrane model of thymosin beta-15

    Article • Peptides, January 2003, Elsevier

    Dr. Evangelia Livaniou

  60. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, November 2001, Elsevier

    Dr. Evangelia Livaniou

  61. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles

    Article • International Journal of Pharmaceutics, June 2001, Elsevier

    Dr. Evangelia Livaniou

  62. Analytical techniques for determining biotin

    Article • Journal of Chromatography A, June 2000, Elsevier

    Dr. Evangelia Livaniou

  63. Determination of biotin levels in cerebrospinal fluid samples

    Article • Journal of Pharmaceutical and Biomedical Analysis, December 1999, Elsevier

    Dr. Evangelia Livaniou

  64. Cerebrospinal fluid levels of biotin in various neurological disorders

    Article • Acta Neurologica Scandinavica, June 1999, Hindawi Publishing Corporation

    Dr. Evangelia Livaniou

  65. Investigation of the epitopic structure of thymosin β10 by epitope mapping experiments

    Article • Peptides, March 1999, Elsevier

    Dr. Evangelia Livaniou

  66. Biotin recycling impairment in phenylketonuric children with seborrheic dermatitis

    Article • International Journal of Dermatology, December 1998, Wiley

    Dr. Evangelia Livaniou

  67. Direct ELISA Method for the Specific Determination of Prothymosin Alpha in Human Specimens

    Article • Journal of Immunoassay, November 1998, Taylor & Francis

    Dr. Evangelia Livaniou

  68. Biotin Plasma Levels of theHuman Fetus

    Article • Neonatology, January 1998, Karger Publishers

    Dr. Evangelia Livaniou

  69. Indirect Enzyme-Linked Method for Determining Biotin in Human Serum

    Article • Journal of Immunoassay, February 1997, Taylor & Francis

    Dr. Evangelia Livaniou

  70. A simple approach to the synthesis of muramic acid and isomuramic acid: 1H and 13C NMR characterisation

    Article • Carbohydrate Research, January 1997, Elsevier

    Dr. Evangelia Livaniou

  71. [46] Determination of serum biotinidase activity with radioiodinated biotinylamide analogs

    Article • January 1997, Elsevier

    Dr. Evangelia Livaniou

  72. Preliminary findings on the expression of thymosin beta-10 in human breast cancer

    Article • British Journal of Cancer, November 1996, Springer Science + Business Media

    Dr. Evangelia Livaniou

  73. Solid-phase synthesis of thymosin β10using a p-cyanotrityl resin. Chemical characterization and immunochemical control of the synthetic peptide

    Article • Journal of the Chemical Society Perkin Transactions 1, January 1996, Royal Society of Chemistry

    Dr. Evangelia Livaniou

  74. Development of Specific Anti-Thymosin β 10 Antipeptide Antibodies for Application in Immunochemical Techniques

    Article • Peptides, January 1996, Elsevier

    Dr. Evangelia Livaniou

  75. Large-scale chromatofocusing-based method for isolating thymosin β4 and thymosin β9 from bovine tissues

    Article • Journal of Chromatography B Biomedical Sciences and Applications, December 1994, Elsevier

    Dr. Evangelia Livaniou

  76. Theoretical and experimental epitope mapping of thymosin β4

    Article • Journal of Immunological Methods, December 1994, Elsevier

    Dr. Evangelia Livaniou

  77. FC15 biotin levels in human cerebrospinal fluid

    Article • European Journal of Pharmaceutical Sciences, September 1994, Elsevier

    Dr. Evangelia Livaniou

  78. High-performance liquid chromatographic separation of biotinylamide analogues used as substrates in biotinidase radioassays

    Article • Journal of Chromatography B Biomedical Sciences and Applications, June 1994, Elsevier

    Dr. Evangelia Livaniou

  79. A 125I-radioimmunoassay for diethylstilbestrol in serum of patients with prostatic cancer treated with stilphostrol

    Article • Clinica Chimica Acta, July 1993, Elsevier

    Dr. Evangelia Livaniou

  80. A thymosin β4 ELISA using an antibody against the N terminal fragment thymosin β4[1–14]

    Article • Journal of Immunological Methods, January 1992, Elsevier

    Dr. Evangelia Livaniou

  81. Preparation of the N-(4'-hydroxy-[3'-125I]iodophenethyl)-6-(4-O-diethylstilbestryl)hexanamide for diethylstilbestrol radioimmunoassays

    Article • Steroids, January 1992, Elsevier

    Dr. Evangelia Livaniou

  82. Isolation of mono- and di-iodine 125 tyramines for conjugation labelling

    Article • European Journal of Pediatrics, December 1991, Springer Science + Business Media

    Dr. Evangelia Livaniou

  83. Biotinidase radioassay using an 125I-biotin derivative, avidin, and polyethylene glycol reagents

    Article • Analytical Biochemistry, August 1991, Elsevier

    Dr. Evangelia Livaniou

  84. Plasma Biotin Levels in Neonates

    Article • Neonatology, January 1991, Karger Publishers

    Dr. Evangelia Livaniou

  85. Biotin radioligand assay with an 125I-labeled biotin derivative, avidin, and avidin double-antibody reagents.

    Article • Clinical Chemistry, November 1987, Oxford University Press (OUP)

    Dr. Evangelia Livaniou

  86. Serum Biotin Levels in Patients Undergoing Chronic Hemodialysis

    Article • January 1987, Karger Publishers

    Dr. Evangelia Livaniou